Author

M. Muenchhoff

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:flow cytometry· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. B. Krug· 2 shared C. Scherer· 2 shared E. Winheim· 2 shared J. Hellmuth· 2 shared J. Kranich· 2 shared K. Lutz· 2 shared K. Stark· 2 shared L. Rausch· 2 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. B. Krug

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients

L. Rausch, K. Lutz, M. Schifferer, E. Winheim, R. Gruber, L. Rinke, J. Hellmuth, C. Scheerer, M. Muenchhoff, C. Mandel, M. Bergwelt-Baildon, M. Simons, T. Straub, A. B. Krug, J. Kranich, T. Brocker

The paper identifies PS+ PMPs as a marker for disease severity in COVID-19 by showing their correlation with immune dysfunction and clinical outcomes.

bioRxiv · Jun 18, 2021Immunology

Impaired function and delayed regeneration of dendritic cells in COVID-19

E. Winheim, L. Rinke, K. Lutz, A. Reischer, A. Leutbecher, L. Wolfram, L. Rausch, J. Kranich, P. R. Wratil, J. Huber, D. Baumjohann, S. Rothenfusser, J. Hellmuth, C. Scherer, M. Muenchhoff, , A. B. Krug

This study examines dendritic cell and monocyte function and regeneration in COVID-19 patients, finding persistent reductions and functional impairments linked to disease severity.

bioRxiv · May 26, 2021 · PreprintImmunology

Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infection

K. Pekayvaz, A. Leunig, R. Kaiser, S. Brambs, M. Joppich, A. Janjic, O. Popp, V. Polewka, L. E. Wange, C. Gold, M. Kirchner, M. Muenchhoff, J. C. Hellmuth, C. Scherer, T. Eser, , L. Nicolai

This study identifies an early interferon-stimulated gene (ISG) upregulation as a protective immune signature in non-pneumonic SARS-CoV-2 infection, preventing progression to pneumonia.

bioRxiv · Feb 3, 2021Immunology